| Literature DB >> 30583597 |
Francesca Bonvicini1, Silvia Cilloni2, Rossano Fornaciari3, Carmen Casoni4, Cristina Marchesi5, Marina Greci6, Lucia Monici7, Fausto Nicolini8, Marco Vinceti9.
Abstract
Tuberculosis (TB) is a serious public health problem in many regions of the world, especially in the poorest areas. For this reason, screening for active and latent forms must be considered when dealing with high-risk groups such as irregular immigrants in Western countries. We conducted a retrospective cohort study by recruiting subjects aged ≥15 years who underwent a tuberculin skin test at a dedicated National Health Service Centre in a northern Italian province between 1 January 2012 and 31 December 2013. These participants were followed up until 31 December 2016. We aimed at evaluating an experimental protocol for active and latent tuberculosis screening, focusing on patient compliance, feasibility, and capability to detect clinical forms of the disease. We enrolled 368 irregular immigrants, i.e., immigrants not having a valid residence permit and who were therefore not entitled to choose a general practitioner. In total, 90.22% of these completed all the steps for the screening of active TB, while 87.33% also undertook screening for the latent form of the disease. Homelessness, self-reported prostitution, female sex, and employment status adversely affected compliance. Chronic alcohol consumption was associated with increased risk of no beginning or interruption of the procedures. All of the five patients with active TB successfully completed the treatment. Overall, adherence to the screening program was high compared to other studies in immigrants, possibly owing to organizational factors such as the availability of cultural mediators, the network between the different health services, the presence of dedicated nursing staff and a free-of-charge service. In addition, selected vulnerable subgroups should be targeted using tailored screening and follow-up programs.Entities:
Keywords: immigrants; public health; screening for tuberculosis; tuberculosis
Mesh:
Year: 2018 PMID: 30583597 PMCID: PMC6339090 DOI: 10.3390/ijerph16010028
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Procedures for active tuberculosis (TB) and latent tuberculosis infection (LTBI) screening at the Centre for Health of Foreign Family (CFF) of Reggio Emilia. TST: Tuberculin Skin Test; CXR: chest X-ray; PE: Pneumological Examination; POS: positive; NEG: negative.
Compliance with the different steps of the algorithm and treatment outcomes.
| Steps of the Algorithm | % | |
|---|---|---|
|
| 349/368 | 94.8 |
|
| 134/151 | 88.7 |
|
| 89/110 | 80.9 |
|
| 78/84 | 92.9 |
|
| 332/368 | 90.2 |
| negative TST with CXR indication | 12/12 | 100 |
| positive TST | 122/139 | 87.8 |
|
| 317/363 | 87.3 |
| negative TST with CXR indication | 12/12 | 100 |
| positive TST | 107/134 | 79.9 |
|
| ||
| refusal or voluntary interruption | 8/28 | 28.6 |
| medical contraindication or interruption | 6/28 | 21.4 |
| treatment completed | 14/28 | 50.0 |
| 17/41 | 41.5 | |
| voluntary interruption | 18/41 | 43.9 |
| completed | 6/41 | 14.6 |
|
| 5/5 | 100 |
|
| 281/368 | 76.4 |
| negative TST with CXR indication | 12/12 | 100 |
| positive TST | 71/139 | 51.1 |
TST: tuberculin skin test; CXR: chest-X-ray; QFT: quantiferon test; PE: pneumological examination; TB: tuberculosis; LTBI: latent tuberculosis infection.
Association between selected characteristics and compliance with screening for active tuberculosis (TB).
| Sample Characteristics | TB Screening Started/Completed | Bivariate OR (95% CI) | Multivariate OR (95% CI) | |||
|---|---|---|---|---|---|---|
|
| % | |||||
|
| ||||||
| Male | 222/243 | 91.36 | 1.00 (reference) | 1.00 (reference) | ||
| Female | 110/125 | 88.00 | 0.69 (0.34–1.40) | 0.306 | 0.47 (0.22–1.03) | 0.061 |
|
| ||||||
| 15–24 | 90/97 | 92.78 | 1.00 (reference) | 1.00 (reference) | ||
| 25–34 | 113/130 | 86.92 | 0.52 (0.21–1.30) | 0.161 | 0.44 (0.16–1.18) | 0.103 |
| 35–44 | 87/95 | 91.58 | 0.85 (0.29–2.43) | 0.756 | 0.57 (0.18–1.84) | 0.344 |
| ≥45 | 42/46 | 91.30 | 0.82 (0.23–2.94) | 0.757 | 0.90 (0.20–4.03) | 0.891 |
| Continuous OR | 0.99 (0.70–1.41) | 0.972 | 0.96 (0.64–1.43) | 0.827 | ||
|
| ||||||
| Africa | 103/111 | 92.79 | 1.00 (reference) | 1.00 (reference) | ||
| Eastern Mediterranean | 75/83 | 90.36 | 0.73 (0.26–2.03) | 0.544 | 0.75 (0.25–2.27) | 0.607 |
| Europe | 60/72 | 83.33 | 0.39 (0.15–1.00) | 0.051 | 0.44 (0.15–1.30) | 0.138 |
| SE Asia/West Pacific | 85/90 | 94.44 | 1.32 (0.42–4.19) | 0.637 | 2.49 (.57–10.87) | 0.226 |
| Americas | 9/12 | 75.00 | 0.23 (0.05–1.04) | 0.056 | 0.27 (0.05–1.44) | 0.125 |
|
| 1.26 (0.89–1.79) | 0.187 | 1.15 (0.79–1.69) | 0.458 | ||
|
| ||||||
| No | 211/236 | 89.41 | 1.00 (reference) | |||
| Yes | 121/132 | 91.67 | 1.30 (0.62–2.74) | 0.485 | ||
|
| ||||||
| No | 249/280 | 88.93 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 83/88 | 94.32 | 2.07 (0.78–5.49) | 0.145 | 3.23 (1.04–10.05) | 0.043 |
|
| 1.36 (0.88–2.12) | 0.168 | 1.49 (0.93–2.40) | 0.101 | ||
|
| 0.89 (0.52–1.50) | 0.652 | 0.90 (0.51–1.58) | 0.721 | ||
|
| ||||||
| No | 234/258 | 90.70 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 90/102 | 88.24 | 0.77 (0.37–1.60) | 0.484 | 0.79 (0.32–1.96) | 0.612 |
|
| ||||||
| <5 | 223/252 | 88.49 | 1.00 (reference) | 1.00 (reference) | ||
| ≥5 | 102/109 | 93.58 | 1.89 (0.80–4.47) | 0.144 | 3.29 (1.18–9.22) | 0.023 |
| Continuous OR | 1.06 (0.96–1.18) | 0.248 | 1.18 (0.72–1.92) | 0.513 | ||
|
| ||||||
| No | 313/345 | 90.72 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 19/23 | 82.61 | 0.49 (0.16–1.52) | 0.213 | 0.35 (0.10–1.25) | 0.107 |
|
| ||||||
| No | 304/340 | 89.41 | - | |||
| Yes | 28/28 | 100.00 | - | 0.070 *** | ||
|
| ||||||
| No | 323/357 | 90.48 | 1.00 (reference) | |||
| Yes | 9/11 | 81.82 | 0.47 (0.10–2.28) | 0.352 | ||
|
| ||||||
| No | 323/359 | 89.97 | - | |||
| Yes | 9/9 | 100.00 | - | 0.319 *** | ||
|
| ||||||
| Negative | 210/210 | 100.00 | - | |||
| Positive | 122/139 | 87.77 | - | 0.000 *** | ||
°: TB incidence in the country of origin is sub-divided into 4 categories: 0–49, 50–99, 100–199, ≥200 per 100,000 population/year. *: Meaning at least one among cough, hemoptysis, fever, chest pain, weight loss, fatigue, night sweats, chills or loss of appetite. **: Education is sub-divided into three categories: illiterate/primary school, secondary school, high school/degree. **°: Knowledge of Italian is sub-divided into three categories: none, sufficient, good. ***: Two-sample Mann–Whitney test. TB: tuberculosis; LTBI: latent tuberculosis infection; TST: tuberculin skin test; SE Asia: South-East Asia; OR: odds ratio; CI: confidence interval.
Association between selected characteristics and compliance with screening for latent TB infection (LTBI).
| Sample Characteristics | LTBI Screening Started/Completed | Bivariate OR (95% CI) | Multivariate OR (95% CI) | |||
|---|---|---|---|---|---|---|
|
| % | |||||
|
| ||||||
| Male | 211/241 | 87.55 | 1.00 (reference) | 1.00 (reference) | ||
| Female | 106/122 | 86.89 | 0.94 (0.49–1.80) | 0.857 | 0.76 (0.38–1.54) | 0.451 |
|
| ||||||
| 15–24 | 88/97 | 90.72 | 1.00 (reference) | 1.00 (reference) | ||
| 25–34 | 107/127 | 84.25 | 0.55 (0.24–1.26) | 0.157 | 0.54 (0.22–1.31) | 0.173 |
| 35–44 | 80/93 | 86.02 | 0.63 (0.26–1.55) | 0.314 | 0.57 (0.21–1.56) | 0.273 |
| ≥45 | 42/46 | 91.30 | 1.07 (0.31–3.69) | 0.910 | 1.39 (0.33–5.86) | 0.658 |
| Continuous OR | 0.98 (0.72–1.34) | 0.892 | 1.01 (0.70 –1.45) | 0.956 | ||
|
| ||||||
| Africa | 97/109 | 88.99 | 1.00 (reference) | 1.00 (reference) | ||
| Eastern Mediter. | 73/83 | 87.95 | 0.90 (0.37–2.20) | 0.823 | 0.93 (0.35–2.47) | 0.892 |
| Europe | 60/72 | 83.33 | 0.62 (0.26–1.47) | 0.275 | 0.72 (0.27–1.91) | 0.509 |
| SE Asia/West Pacific | 78/87 | 89.66 | 1.07 (0.43–2.67) | 0.881 | 2.39 (0.72–7.93) | 0.155 |
| Americas | 9/12 | 75.00 | 0.37 (0.09–1.56) | 0.177 | 0.32 (0.06–1.64) | 0.174 |
|
| 1.11 (0.82–1.52) | 0.489 | 0.99 (0.70–1.40) | 0.975 | ||
|
| ||||||
| No | 203/235 | 86.38 | 1.00 (reference) | |||
| Yes | 114/128 | 89.06 | 1.28 (0.66–2.51) | 0.464 | ||
|
| ||||||
| No | 240/279 | 86.02 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 77/84 | 91.67 | 1.79 (0.77–4.16) | 0.178 | 2.38 (0.92–6.17) | 0.073 |
|
| 1.09 (0.73–1.63) | 0.660 | 1.09 (0.71–1.68) | 0.688 | ||
|
| 1.13 (0.68–1.87) | 0.636 | 1.15 (0.67–1.95) | 0.616 | ||
|
| ||||||
| No | 228/257 | 88.72 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 81/98 | 82.65 | 0.61 (0.32–1.16) | 0.131 | 0.56 (0.25–1.26) | 0.162 |
|
| ||||||
| <5 | 215/249 | 86.35 | 1.00 (reference) | 1.00 (reference) | ||
| ≥5 | 95/107 | 88.79 | 1.25 (0.62–2.52) | 0.530 | 1.88 (0.80–4.40) | 0.145 |
| Continuous OR | 1.04 (0.95–1.13) | 0.376 | 0.99 (0.64–1.54) | 0.972 | ||
|
| ||||||
| No | 299/340 | 87.94 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 18/23 | 78.26 | 0.49 (0.17–1.40) | 0.185 | 0.35 (0.11–1.12) | 0.076 |
|
| ||||||
| No | 290/335 | 86.57 | 1.00 (reference) | |||
| Yes | 27/28 | 96.43 | 4.19 (0.56–31.60) | 0.165 | ||
|
| ||||||
| No | 309/352 | 87.78 | 1.00 (reference) | |||
| Yes | 8/11 | 72.73 | 0.37 (0.09–1.45) | 0.155 | ||
|
| ||||||
| No | 309/355 | 87.04 | - | |||
| Yes | 8/8 | 100.00 | - | 0.277 *** | ||
|
| ||||||
| Negative | 210/210 | 100.00 | - | |||
| Positive | 107/134 | 79.85 | - | 0.000 *** | ||
°: TB incidence in the country of origin is sub-divided into four categories: 0–49, 50–99, 100–199, ≥200 per 100,000 population/year. *: Meaning at least one among cough, hemoptysis, fever, chest pain, weight loss, fatigue, night sweats, chills or loss of appetite. **: Education is sub-divided into three categories: illiterate/primary school, secondary school, high school/degree. **°: Knowledge of Italian is sub-divided into three categories: none, sufficient, good. ***: Two-sample Mann–Whitney test. TB: tuberculosis; LTBI: latent tuberculosis infection; TST: tuberculin skin test; SE Asia: South-East Asia.
Association between selected characteristics and compliance with the full protocol (bivariate and multivariate analysis).
| Protocol Started/Completed | Bivariate OR (95% CI) | Multivariate | ||||
|---|---|---|---|---|---|---|
| Sample characteristics |
| % | OR (95% CI) | |||
|
| ||||||
| Male | 183/243 | 75.31 | 1.00 (reference) | 1.00 (reference) | ||
| Female | 98/125 | 78.40 | 1.19 (0.71–1.99) | 0.509 | 1.18 (0.65–2.12) | 0.588 |
|
| ||||||
| 15–24 | 83/97 | 85.57 | 1.00 (reference) | 1.00 (reference) | ||
| 25–34 | 97/130 | 74.62 | 0.50 (0.25–0.99) | 0.046 | 0.44 (0.21–0.93) | 0.031 |
| 35–44 | 70/95 | 73.68 | 0.47 (0.23–0.98) | 0.043 | 0.39 (0.17–0.88) | 0.024 |
| ≥45 | 31/46 | 67.39 | 0.35 (0.15–0.81) | 0.014 | 0.26 (0.10–0.68) | 0.006 |
| Continuous OR | 0.74 (0.58–0.94) | 0.014 | 0.67 (0.50–0.89) | 0.007 | ||
|
| ||||||
| Africa | 85/111 | 76.58 | 1.00 (reference) | 1.00 (reference) | ||
| Eastern Mediterranean | 62/83 | 74.70 | 0.90 (0.47–1.75) | 0.763 | 0.87 (0.41–1.85) | 0.723 |
| Europe | 49/72 | 68.06 | 0.65 (0.34–1.26) | 0.205 | 0.90 (0.42–1.97) | 0.801 |
| SE Asia/West Pacific | 76/90 | 84.44 | 1.66 (0.81–3.41) | 0.167 | 4.48 (1.57–12.73) | 0.005 |
| Americas | 9/12 | 75.00 | 0.92 (0.23–3.64) | 0.903 | 0.67 (0.14–3.16) | 0.617 |
|
| 0.91 (0.72–1.16) | 0.461 | 0.79 (0.59–1.05) | 0.107 | ||
|
| ||||||
| No | 179/236 | 75.85 | 1.00 (reference) | |||
| Yes | 102/132 | 77.27 | 1.08 (0.65–1.79) | 0.758 | ||
|
| ||||||
| No | 212/280 | 75.71 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 69/88 | 78.41 | 1.16 (0.65–2.07) | 0.604 | 1.75 (0.88–3.46) | 0.110 |
|
| 1.18 (0.86–1.62) | 0.306 | 1.24 (0.88–1.74) | 0.220 | ||
|
| 1.26 (0.85–1.89) | 0.254 | 1.30 (0.82–2.04) | 0.265 | ||
|
| ||||||
| No | 201/258 | 77.91 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 75/102 | 73.53 | 0.79 (0.46–1.34) | 0.377 | 0.59 (0.30–1.17) | 0.133 |
|
| ||||||
| <5 | 188/252 | 74.60 | 1.00 (reference) | 1.00 (reference) | ||
| ≥5 | 88/109 | 80.73 | 1.43 (0.82–2.48) | 0.209 | 2.94 (1.44–6.01) | 0.003 |
| Continuous OR | 1.06 (0.99–1.13) | 0.119 | 1.30 (0.90–1.86) | 0.160 | ||
|
| ||||||
| No | 267/345 | 77.39 | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 14/23 | 60.87 | 0.45 (0.19–1.09) | 0.077 | 0.35 (0.13–0.96) | 0.042 |
|
| ||||||
| No | 258/340 | 75.88 | 1.00 (reference) | |||
| Yes | 23/28 | 82.14 | 1.46 (0.54–3.97) | 0.456 | ||
|
| ||||||
| No | 273/357 | 76.47 | 1.00 (reference) | |||
| Yes | 8/11 | 72.73 | 0.82 (0.21–3.16) | 0.774 | ||
|
| ||||||
| No | 272/359 | 75.84 | - | |||
| Yes | 9/9 | 91.67 | - | 0.091 *** | ||
|
| ||||||
| Negative | 210/210 | 100.00 | - | |||
| Positive | 71/139 | 51.08 | - | 0.000 *** | ||
° TB incidence in the country of origin is sub-divided into 4 categories: 0–49, 50–99, 100–199, ≥200 per 100,000 population/year. * Meaning at least one among cough, hemoptysis, fever, chest pain, weight loss, fatigue, night sweats, chills or loss of appetite. ** Education is sub-divided into three categories: illiterate/primary school, secondary school, high school/degree. **° Knowledge of Italian is sub-divided into three categories: none, sufficient, good. *** Two-sample Mann–Whitney test. TST: tuberculin skin test; SE Asia: South-East Asia; TB: tuberculosis.